These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1477928)
21. Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats. Hermens WA; Deurloo MJ; Romeyn SG; Verhoef JC; Merkus FW Pharm Res; 1990 May; 7(5):500-3. PubMed ID: 2367318 [TBL] [Abstract][Full Text] [Related]
22. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment. Arima H; Miyaji T; Irie T; Hirayama F; Uekama K Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455 [TBL] [Abstract][Full Text] [Related]
23. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats. Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281 [TBL] [Abstract][Full Text] [Related]
24. Potential use of gamma-cyclodextrin polypseudorotaxane hydrogels as an injectable sustained release system for insulin. Abu Hashim II; Higashi T; Anno T; Motoyama K; Abd-ElGawad AE; El-Shabouri MH; Borg TM; Arima H Int J Pharm; 2010 Jun; 392(1-2):83-91. PubMed ID: 20298768 [TBL] [Abstract][Full Text] [Related]
25. [Use of water-soluble beta-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenylylacetic acid in rectal delivery]. Arima H; Kondo T; Irie T; Hirayama F; Uekama K; Miyaji T; Inoue Y Yakugaku Zasshi; 1992 Jan; 112(1):65-72. PubMed ID: 1578346 [TBL] [Abstract][Full Text] [Related]
26. Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics. Schipper NG; Verhoef JC; De Lannoy LM; Romeijn SG; Brakkee JH; Wiegant VM; Gispen WH; Merkus FW Br J Pharmacol; 1993 Dec; 110(4):1335-40. PubMed ID: 8306072 [TBL] [Abstract][Full Text] [Related]
27. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state. Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015 [TBL] [Abstract][Full Text] [Related]
28. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats. Shao Z; Li Y; Chermak T; Mitra AK Pharm Res; 1994 Aug; 11(8):1174-9. PubMed ID: 7971720 [TBL] [Abstract][Full Text] [Related]
29. Effect of sugar-modified beta-cyclodextrins on dissolution and absorption characteristics of phenytoin. Tanino T; Ogiso T; Iwaki M Biol Pharm Bull; 1999 Mar; 22(3):298-304. PubMed ID: 10220288 [TBL] [Abstract][Full Text] [Related]
30. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Fernández-Urrusuno R; Calvo P; Remuñán-López C; Vila-Jato JL; Alonso MJ Pharm Res; 1999 Oct; 16(10):1576-81. PubMed ID: 10554100 [TBL] [Abstract][Full Text] [Related]
31. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution. Miyake K; Hirayama F; Uekama K J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700 [TBL] [Abstract][Full Text] [Related]
32. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies. Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339 [TBL] [Abstract][Full Text] [Related]
33. Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins. Mady FM; Farghaly Aly U Drug Des Devel Ther; 2017; 11():1681-1692. PubMed ID: 28652706 [TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced cellular damage: In vitro and in vivo studies. Nagase Y; Arima H; Wada K; Sugawara T; Satoh H; Hirayama F; Uekama K J Pharm Sci; 2003 Dec; 92(12):2466-74. PubMed ID: 14603492 [TBL] [Abstract][Full Text] [Related]
35. [Novel approach of cyclodextrin-based pharmaceutical formulation]. Uekama K Yakugaku Zasshi; 2012; 132(1):85-105. PubMed ID: 22214584 [TBL] [Abstract][Full Text] [Related]
36. Effect of cyclodextrins on biological membrane. I. Effect of cyclodextrins on the absorption of a non-absorbable drug from rat small intestine and rectum. Nakanishi K; Nadai T; Masada M; Miyajima K Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1684-7. PubMed ID: 2208383 [TBL] [Abstract][Full Text] [Related]
37. Isolation, characterization and study of enhancing effects on nasal absorption of insulin in rat of the total saponin from Acanthophyllum squarrosum. Sajadi Tabassi SA; Hosseinzadeh H; Ramezani M; Moghimipour E; Mohajeri SA Curr Drug Deliv; 2006 Oct; 3(4):399-404. PubMed ID: 17076642 [TBL] [Abstract][Full Text] [Related]
38. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride. du Plessis LH; Kotzé AF; Junginger HE Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846 [TBL] [Abstract][Full Text] [Related]
39. Pulmonary absorption of insulin mediated by tetradecyl-beta-maltoside and dimethyl-beta-cyclodextrin. Hussain A; Yang T; Zaghloul AA; Ahsan F Pharm Res; 2003 Oct; 20(10):1551-7. PubMed ID: 14620506 [TBL] [Abstract][Full Text] [Related]
40. The ocular route for systemic insulin delivery in the albino rabbit. Yamamoto A; Luo AM; Dodda-Kashi S; Lee VH J Pharmacol Exp Ther; 1989 Apr; 249(1):249-55. PubMed ID: 2651650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]